Journal article
Pitfalls in estimating piperaquine elimination.
- Abstract:
- By using a sensitive new assay, the terminal elimination half-life of the antimalarial piperaquine in a healthy volunteer was estimated to be 33 days, which is longer than estimated previously. This result illustrates the importance of extended sampling duration and sensitive assay methodologies in characterizing the disposition of slowly eliminated antimalarial drugs.
- Publication status:
- Published
Actions
Access Document
- Publisher copy:
- 10.1128/aac.49.12.5127-5128.2005
Authors
- Journal:
- Antimicrobial agents and chemotherapy More from this journal
- Volume:
- 49
- Issue:
- 12
- Pages:
- 5127-5128
- Publication date:
- 2005-12-01
- DOI:
- EISSN:
-
1098-6596
- ISSN:
-
0066-4804
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:25728
- UUID:
-
uuid:d38fef1a-f5c7-42b9-bc5e-99abef55a3ae
- Local pid:
-
pubs:25728
- Source identifiers:
-
25728
- Deposit date:
-
2012-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record